ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,374.76
      2.56%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aeterna Zentaris Inc (AEZS)

      7. Aeterna Zentaris Inc (AEZS) News

      AEZS

      Aeterna Zentaris (AEZS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AEZS
      DateTimeSourceHeadlineSymbolCompany
      01/09/20148:31AMPR Newswire (Canada)Aeterna Zentaris annonce la fixation du prix du placement public d'actions ordinaires et de bons de souscription de 13,2 M$ USNASDAQ:AEZSAeterna Zentaris Inc
      01/08/20144:05PMPR Newswire (Canada)Aeterna Zentaris annonce un placement public proposé d'actions ordinaires et de bons de souscriptionNASDAQ:AEZSAeterna Zentaris Inc
      01/08/20144:05PMPR Newswire (US)Aeterna Zentaris Announces Proposed Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      01/08/20144:05PMPR Newswire (Canada)Aeterna Zentaris Announces Proposed Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      01/06/201412:00PMPR Newswire (Canada)Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDANASDAQ:AEZSAeterna Zentaris Inc
      01/06/201412:00PMPR Newswire (US)Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDANASDAQ:AEZSAeterna Zentaris Inc
      01/06/201412:00PMPR Newswire (Canada)Aeterna Zentaris : la FDA accepte le dépôt de la demande de nouveau médicament pour macimoréline acétate portant sur la ...NASDAQ:AEZSAeterna Zentaris Inc
      01/03/20147:30AMPR Newswire (US)Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific OfficerNASDAQ:AEZSAeterna Zentaris Inc
      01/03/20147:30AMPR Newswire (Canada)Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific OfficerNASDAQ:AEZSAeterna Zentaris Inc
      01/03/20147:30AMPR Newswire (Canada)Aeterna Zentaris nomme Dr. Richard Sachse, chef de la direction scientifiqueNASDAQ:AEZSAeterna Zentaris Inc
      12/05/20137:04PMZacksNDA for AcelRx's Zalviso Accepted - Analyst BlogNASDAQ:AEZSAeterna Zentaris Inc
      11/25/201311:15AMPR Newswire (Canada)Aeterna Zentaris Announces Closing of US$15.1 Million Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      11/25/201311:15AMPR Newswire (US)Aeterna Zentaris Announces Closing of US$15.1 Million Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      11/25/201311:15AMPR Newswire (Canada)Aeterna Zentaris annonce la clôture du placement public d'actions ordinaires et de bons de souscription de 15,1 M$ USNASDAQ:AEZSAeterna Zentaris Inc
      11/20/20138:22AMPR Newswire (US)Aeterna Zentaris Announces Pricing of US$15.1 Million Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      11/20/20138:22AMPR Newswire (Canada)Aeterna Zentaris annonce la fixation du prix du placement public d'actions ordinaires et de bons de souscription de 15,1 M$ USNASDAQ:AEZSAeterna Zentaris Inc
      11/20/20138:22AMPR Newswire (Canada)Aeterna Zentaris Announces Pricing of US$15.1 Million Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      11/19/20134:05PMPR Newswire (Canada)Aeterna Zentaris Announces Proposed Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      11/19/20134:05PMPR Newswire (US)Aeterna Zentaris Announces Proposed Public Offering of Common Shares and WarrantsNASDAQ:AEZSAeterna Zentaris Inc
      11/19/20134:05PMPR Newswire (Canada)Aeterna Zentaris annonce un placement public proposé d'actions ordinaires et de bons de souscriptionNASDAQ:AEZSAeterna Zentaris Inc
      11/05/20134:48PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      11/05/20134:47PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
      11/05/20134:30PMPR Newswire (US)Aeterna Zentaris Reports Third Quarter 2013 Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
      11/05/20134:30PMPR Newswire (Canada)Aeterna Zentaris Reports Third Quarter 2013 Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
      11/05/20134:30PMPR Newswire (Canada)Aeterna Zentaris annonce ses résultats financiers et d'exploitation du troisième trimestre 2013NASDAQ:AEZSAeterna Zentaris Inc
      11/05/20137:30AMPR Newswire (US)Aeterna Zentaris Submits New Drug Application to FDA for Macimorelin Acetate (AEZS-130) for Evaluation of AGHDNASDAQ:AEZSAeterna Zentaris Inc
      11/05/20137:30AMPR Newswire (Canada)Aeterna Zentaris Submits New Drug Application to FDA for Macimorelin Acetate (AEZS-130) for Evaluation of AGHDNASDAQ:AEZSAeterna Zentaris Inc
      11/05/20137:30AMPR Newswire (Canada)Aeterna Zentaris soumet une demande de nouveau médicament auprès de la FDA pour macimoréline acétate (AEZS-130) pour l'é...NASDAQ:AEZSAeterna Zentaris Inc
      11/01/20137:30AMPR Newswire (Canada)Aeterna Zentaris nomme un chef de la direction commerciale et réitère la nouvelle vision d'entrepriseNASDAQ:AEZSAeterna Zentaris Inc
      11/01/20137:30AMPR Newswire (US)Aeterna Zentaris Appoints Chief Commercial Officer, Reaffirming New Company VisionNASDAQ:AEZSAeterna Zentaris Inc
       Showing the most relevant articles for your search:NASDAQ:AEZS